news
-
ESTRO ANNUAL CONGRESS 2022
- April 8, 2022
European SocieTy for Radiotherapy & Oncology (ESTRO) Annual Meeting
May 6-10, 2022
Copenhagen, Denmark
Booth #C1-615 – Onsite & Online Event -
Patient QA Webinar: VMAT QA Made Easy-Clinical experience of a novel EPID-based dosimetry solution.
- April 6, 2022
VMAT QA Made Easy: Clinical experience of a novel EPID-based dosimetry solution
21 April, 2022
17:00 CET / 11:00am EST -
[Oral Communication] Comparison of absorbed dose calculation algorithms in PLANET® Dose and OpenDose3D
- March 23, 2022
José Alejandro Fragoso Negrín
DOSIsoft SA, Cachan, France & IRCM
Presented at RIV Workshop 2022 -
[Oral Communication] Dosimétrie clinique : expérience Montpelliéraine
- March 23, 2022
Clinical Dosimetry: a Montpellier user experience
Dr Lore Santoro (ICM, Montpellier)
Presented at RIV Workshop 2022 -
[Oral Communication] International clinical dosimetry intercomparison – Conclusion and perspectives
- March 23, 2022
Manuel BARDIES (IRCM Montpellier)
Presented at RIV Workshop 2022 -
[Article] Voxel-wise Supervised Analysis of Tumors with Multimodal Engineered Features to Highlight Interpretable Biological Patterns
- March 18, 2022
Thibault Escobar, Sébastien Vauclin, Fanny Orlhac, Christophe Nioche, Pascal Pineau, et al.
Med Phys. 2022;1–14 | https://doi.org/10.1002/mp.15603 -
MCMA 2022
- March 8, 2022
International Conference on Monte Carlo Techniques for Medical Applications (MCMA)
April 11-13, 2022
Antwerp, Belgium -
Workshop Radiothérapie Interne Vectorisée (RIV)
- February 25, 2022
Radiothérapie Interne Vectorisée (RIV) Seminar
March 14-16, 2022
IRCM – Amphithéâtre Institut du Cancer de Montpellier, France -
WCD 2022: 20-year-involvement in delivering patient safety for cancer care
- February 3, 2022
On 4 February, 2022 DOSIsoft gets involved in the World Cancer Day (WCD)
-
[Customer Testimonial] Gilly Belgian clinic enhances confidence with faster, easier end-to-end patient QA
- January 5, 2022
Medical physicist Michaël Del Re, MPE, Ph.D., at Grand Hôpital de Charleroi Gilly shares his experiences about complete patient Quality Assurance (QA) suite of secondary check (MU2net), pre-treatment check (EPIbeam) and in-vivo check (EPIgray). The real benefit is the freeing up of physicist time. We can check treatment quality faster than before thanks to these three solutions.